A calcium channel blocker flunarizine attenuates the neurotoxic effects of iron

Cell Biology and Toxicology

Volumn 22, Issue 2, 2006, Pages 119-125

  Bostanci, M Örner ^a   Baǧirici, Faruk ^a   Canan, Sinan ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Cell death; Flunarizine; Hippocampus; Iron; Stereology

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; FERRIC CHLORIDE; FLUNARIZINE; IRON; SODIUM CHLORIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS; MALE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RAT STRAIN; STEREOLOGY;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DRUG ANTAGONISM; FLUNARIZINE; HIPPOCAMPUS; IRON; MALE; NEURONS; PYRAMIDAL CELLS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33644870517     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-006-0037-9     Document Type: Article

References (43)

1. Aisen P, Wessling-Resnick M, Leibold EA. Iron metabolism. Curr Opin Chem Biol. 1999;3:200-6.
2. Albers GW, Goldberg MP, Choi DW. Do NMDA antagonists prevent neuronal injury? Yes. Arch Neurol. 1992;49:418-20.
3. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radicals reactions. J Free Rad Biol Med. 1985;1:3-25.
4. Bagirici F, Gokce FM, Demir S, Marangoz C. Calcium channel blocker flunarizine suppresses epileptiform activity induced by penicillin in rats. Neurosci Res Cummun. 2001;28:135-40.
5. Beal MF. Aging, energy and oxidative stress in neurodegenerative disease. Ann Neurol. 1995;38:357-66.
6. Bostanci MO, Bagirici F, Korkmaz A. The neurotoxic effect of iron on pyramidal cell number in rat hippocampus: A stereological study. Neurosci Res Cummun. 2003;32:151-9.
7. Braughler JM, Duncan LA, Chase RL. The involvement of iron in lipid peroxidation. J Biol Chem. 1986;261:10282-9.
8. Carbone E, Lux HD. A low voltage activated, fully inactivating calcium channel in vertebrate sensory neurons. Nature. 1984;310:501-2.
9. Chakraborti T, Das S, Mondal M, Roychoudhury S, Chakraborti S. Oxidant, mitochondria and calcium: an overview. Cell Signal. 1999;11:77-85.
10. Choi DV. Glutamate neurotoxicity and disease of the nervous system. Neuron. 1988;1:623.
11. Dawson R, Beal MF, Bondy SC, Di Monte DA, Ison GE. Excitotoxins, aging and environmental neurotoxins: Implications for understanding human neurodegenerative diseases. Toxicol Applied Pharmacol. 1995;134:2553-62.
12. Deibel MA, Ehmann WD, Markesbery WR. Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci. 1996;143:137-42.
13. Farber JL. The role of calcium in cell death. Life Sci. 1981;29:1289-95.
14. Flayn CJ, Farooqui AA, Horocks LA. Ischemia and Hypoxia. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds. Basic Neurochemistry, Molecular, Cellular and Medical Aspects. New York: Raven Pres; 1989: 783.
15. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases. J Neurochem. 1994;63:793-807.
16. Gundersen HJ. Stereology of arbitrary particles. A review of unbiased number and size estimator and the presentation of some new ones, in memory of William R. Thompson. J Microsc 1986;143:3-45.
17. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB. A some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988;96:379-94.
18. Hansen AK, Zeuthen T. Extracellular ion concentrations during spreading depression and ischemia in the rat brain cortex. Acta Physiol Scand. 1981;113:437-45.
19. Herbelte LG, Katz AM. Molecular model for the binding of 1,4-dhydropyridine calcium channel antagonists to their receptors in the heart: drug "imaging" in membranes in considerations for drug design. In: Venter JC, Triggle D, eds. Structure and physiology of the slow inward calcium channel. New York: Alan Rliss Inc; 1987: 89.
20. Izumi Y, Benz AM, Clifford DB, Zorumski CF. Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci Let. 1992;135:227-30.
21. Landfield PW, Thibault O, Mazzanti ML, Porter NM, Kerr DS. Mechanism of neuronal death in brain aging and Alzheimer's disease: Role of endocrine-mediated calcium dyshomeostasis. J Neurobiol. 1992;23:1247-60.
22. Leysen JM, Gommeron W. The Pharmacological Basis of Migraine Therapy. In: Amery WK, Van Nueten JM, Wauquier A, eds. In vitro binding profile of drugs used in migraine. London: Pitman; 1984:255-67.
23. Meyerhoff JL, Lee JK, Rittase BW, Tsang AY, Yourick DL. Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat. Brain Res. 2004;1016:139-44.
24. Orrenius S, Ankarcrona M, Nicotera P. Mechanism of calcium related cell death. Adv Neurol. 1996;71:137-51.
25. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation. J Neurochem. 1988;51:1960-3.
26. Porter NA, Caldwell SE, Mills KA. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 1995;30:277-90.
27. Qian ZM, Wang Q, Pu Y. Brain iron and neurological disorders. Chin Med J. 1997;110:455-8.
28. Qian ZM, Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev. 1998;27:257-67.
29. Robb SJ, Robb-Gaspers LD, Scaduto RC, Jr Thomas AP, Connor JR. Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J Neurosci Res. 1999;55:674-86.
30. Samudralwer DL, Diprete CC, Ni B-F, Ehmann WD, Markesbery WR. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J Neurol Sci. 1995;130:139-45.
31. Sayre LM, Perry G, Smith MA. Redox metals and neurodegenerative disease. Curr Opin Chem Biol. 1999;3:220-5.
32. Schanne FAX, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: A final common pathway. Science. 1979;206:700-2.
33. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc. 1984;134:127-36.
34. Swaiman KF. Hallervorden-Spatz and brain iron metabolism. Arch Neurol. 1991;48:1285-93.
35. Tytgat J, Vereecke J, Carmeliet E. Differential effects of verapamil and flunarizine on cardiac L-type and T-type Ca channels. Naunyn Schmiedebergs Arch Pharmacol. 1988;337:690-2.
36. Uematsu D, Araki N, Greenberg JH. Alterations in cytosolic free calcium in the cat cortex during bicuculline-induced epilepsy. Brain Res Bull. 1990;24:285-8.
37. Weiner DA. Calcium Channel Blockers. Med Clin North America. 1988;72:83-115.
38. West MJ, Slomianka L, Gundersen HJG. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. The Anatomical Record. 1991;231:482-97.
39. Willmore LJ, Sypert GW, Munson JB. Recurrent seizures induced by cortical iron injection: A model of posttraumatic epilepsy. Ann Neurol. 1978;4:329-36.
40. 3 injection into rat isocortex. Brain Res. 1983;277:393-6.
41. Willmore LJ, Triggs WJ. Iron-induced lipid peroxidation and brain injury responses. Int J Dev Neurosci. 1991;9:175-80.
42. Youdim MB. Iron in the brain: Implication for Parkinson's and Alzheimer's diseases. Mt Sinai J Med. 1998;55:97-101.
43. Zaleska MM, Floyd RA. Regional lipid peroxidation in rat brain in vitro possible role of endogenous iron. Neurochem Res. 1985;10:397-410.